Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | EVP, Regional Businesses | March 04, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,122 |
Ending reported balance
After 2026-03-05 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-03-04 · Grant · Acquired 11,364 · Balance 78,486 F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Row 2 · 2026-03-04 · Tax withholding · Disposed 5,806 · Balance 72,680 F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Row 3 · 2026-03-05 · Sale · Disposed 5,558 · Balance 67,122 F3: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |
| Common StockSEC Table I · non-derivative | Indirect401(k)/SDCP | 4,502 |
Reported balance
Holding disclosure · report date 2026-03-04 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 4,502 F4: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
F3: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
F4: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2019 Filed Feb 26, 2019 00:53 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 336 | $88.39 | $29,699.04 |
DisclosureSEC source: 0001022079-19-000038 · wf-form4_155114241191010.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,953 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:20 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 40,765 | $0.00 Strike: $86.63 | $0.00 |
DisclosureSEC source: 0001022079-19-000021 · wf-form4_155070483638553.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,765 Underlying: Common Stock · 40,765 shares Expires 2029-02-18 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:20 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000021 · wf-form4_155070483638553.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,289 F1 · shares: Represents an award of restricted share units. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,556 | $101.00 | $561,156.00 |
DisclosureSEC source: 0001022079-18-000085 · wf-form4_152038297008615.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,941 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 5,393 | $101.00 | $544,693.00 |
DisclosureSEC source: 0001022079-18-000085 · wf-form4_152038297008615.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,497 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 10,949 | $101.00 | $1,105,849.00 |
DisclosureSEC source: 0001022079-18-000085 · wf-form4_152038297008615.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,890 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23,2015, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 21:58 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 572 | $104.99 | $60,054.28 |
DisclosureSEC source: 0001022079-18-000064 · wf-form4_151994150641810.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,941 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:58 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,248 | $104.10 | $129,916.80 |
DisclosureSEC source: 0001022079-18-000064 · wf-form4_151994150641810.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,513 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:58 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 556 | $101.43 | $56,395.08 |
DisclosureSEC source: 0001022079-18-000064 · wf-form4_151994150641810.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,761 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 397 | $102.74 | $40,787.78 |
DisclosureSEC source: 0001022079-18-000052 · wf-form4_151976745800470.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,317 F2 · shares: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,212 | $101.43 | $122,933.16 |
DisclosureSEC source: 0001022079-18-000052 · wf-form4_151976745800470.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,714 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 386 | $102.69 | $39,638.34 |
DisclosureSEC source: 0001022079-18-000052 · wf-form4_151976745800470.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,926 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 33,103 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000018 · wf-form4_151925900684795.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,103 Underlying: Common Stock · 33,103 shares Expires 2028-02-19 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000018 · wf-form4_151925900684795.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,312 F1 · shares: Represents an award of restricted share units. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 21,294 | $52.17 Strike: $52.17 | $1,110,801.51 |
DisclosureSEC source: 0001022079-18-000008 · wf-form4_151700297271754.xml · derivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,294 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 21,294 | $104.00 | $2,214,576.00 |
DisclosureSEC source: 0001022079-18-000008 · wf-form4_151700297271754.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,415 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 21,294 | $52.17 | $1,110,801.51 |
DisclosureSEC source: 0001022079-18-000008 · wf-form4_151700297271754.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,595 | $56.12 Strike: $56.12 | $370,111.40 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · derivative · entry 13 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,595 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. F9 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2014, the second on February 25, 2015 and the final on February 25, 2016. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 44,000 | $57.61 Strike: $57.61 | $2,534,620.00 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · derivative · entry 12 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,000 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. F8 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 27, 2013, the second on February 27, 2014 and the final on February 27, 2015. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 9,167 | $57.35 Strike: $57.35 | $525,681.62 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · derivative · entry 11 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,167 shares Expires 2021-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. F7 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 16, 2012, the second on May 16, 2013 and the final on May 16, 2014. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 177 | $108.15 | $19,142.55 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 9 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,415 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 6,418 | $107.54 | $690,217.39 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 8 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,592 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $107.12 to $108.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,364 | $108.14 | $147,504.32 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 7 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,010 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. F5 · price: This transaction was executed in multiple trades at prices ranging from $108.12 to $108.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 42,636 | $107.52 | $4,584,222.72 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 6 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,374 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $107.12 to $108.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 315 | $108.16 | $34,069.14 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 5 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,010 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $108.15 to $108.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 8,852 | $107.54 | $951,961.78 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,325 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $107.14 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 6,595 | $56.12 | $370,111.40 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 44,000 | $57.61 | $2,534,620.00 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 9,167 | $57.35 | $525,727.45 |
DisclosureSEC source: 0001022079-17-000150 · wf-form4_149807682728949.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017. Read SEC document |
| May 19, 2017 Filed May 23, 2017 20:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GiftCommon Stock | 4,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000143 · wf-form4_149557209354018.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,415 Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 6,028 | $98.29 | $592,492.12 |
DisclosureSEC source: 0001022079-17-000104 · wf-form4_148883634583941.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,155 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on January 30, 2017. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,134 | $98.25 | $111,415.50 |
DisclosureSEC source: 0001022079-17-000104 · wf-form4_148883634583941.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,183 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on January 30, 2017. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 6,492 | $98.12 | $636,995.04 |
DisclosureSEC source: 0001022079-17-000104 · wf-form4_148883634583941.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,317 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 12,520 | $98.12 | $1,228,462.40 |
DisclosureSEC source: 0001022079-17-000104 · wf-form4_148883634583941.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,809 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:49 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 585 | $96.42 | $56,405.70 |
DisclosureSEC source: 0001022079-17-000086 · wf-form4_148849135447499.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,289 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 638 | $95.68 | $61,043.84 |
DisclosureSEC source: 0001022079-17-000066 · wf-form4_148831826525945.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,874 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:13 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 37,565 | $95.80 Strike: $95.80 | $3,598,539.18 |
DisclosureSEC source: 0001022079-17-000046 · wf-form4_148789157677463.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,565 Underlying: Common Stock · 37,565 shares Expires 2027-02-21 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:13 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000046 · wf-form4_148789157677463.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,512 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,615 | $94.65 | $152,858.14 |
DisclosureSEC source: 0001022079-17-000027 · wf-form4_148736732847576.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,380 F1 · price: This transaction was executed in multiple trades at prices ranging from $94.56 to $94.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,740 | $93.85 | $163,299.00 |
DisclosureSEC source: 0001022079-17-000021 · wf-form4_148719467348750.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,995 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 37,414 | $56.12 Strike: $56.12 | $2,099,673.68 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · derivative · entry 8 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,595 Underlying: Common Stock · 37,414 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 42,586 | $52.17 Strike: $52.17 | $2,221,498.69 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · derivative · entry 7 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,294 Underlying: Common Stock · 42,586 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 37,414 | $90.40 | $3,382,075.94 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 5 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,735 F3 · price: This transaction was executed in multiple trades at prices ranging from $90.15 to $90.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 37,414 | $56.12 | $2,099,673.68 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 11,486 | $91.61 | $1,052,255.43 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,735 F2 · price: This transaction was executed in multiple trades at prices ranging from $91.14 to $91.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 31,100 | $90.42 | $2,812,030.90 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,221 F1 · price: This transaction was executed in multiple trades at prices ranging from $90.14 to $91.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 30, 2017 Filed Feb 2, 2017 01:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 42,586 | $52.17 | $2,221,498.69 |
DisclosureSEC source: 0001022079-17-000007 · wf-form4_148599862225312.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Clin. Franchise Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.